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A B S T R A C T
Introduction: Although it is well known that ES alters cortical excitability, little is known about the
relationship between ES outcome and cortical excitability. Transcranial magnetic stimulation has been
successfully used to evaluate cortical excitability in epilepsy patients. The present study aimed to assess
the value of the motor threshold (MT) and cortical silent period (CSP) as predictors of the outcome of
temporal lobe epilepsy surgery (TLES).
Materials and methods: Epileptic foci in the epilepsy patients were identiﬁed via video-electroencepha-
lography (v-EEG) monitoring, brain magnetic resonance imaging (MRI), single-photon emission
computed tomography (SPECT), and positron emission tomography (PET), and neurophysiological
testing. MT, CSP-150, and CSP-max were measured in 10 epilepsy patients on both the ipsilateral and
contralateral side of the epileptic focus 1 week before and 3 months after TLES. Pre- and post-operative
MT and CSP measurements were compared, and the results were interpreted based on the clinical
outcome of TLES.
Results: Mean follow-up period was 28.8 months. In all, 8 patients were seizure-free post TLES, whereas
in 2 patients seizures persisted. No signiﬁcant differences were observed in ipsilateral or contralateral
hemisphere MT measurements before and after surgery. Both CSP-150 and CSP-max values in the non-
focal hemispheres decreased in the 8 patients that were seizure-free post TLES, whereas no differences
were observed in the 2 patients with seizures that persisted post TLES.
Conclusions: The present ﬁndings indicate that monitoring pre- and post-TLES CSP changes may be
predictive of the early clinical outcome of TLES.
 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
Seizure
jou r nal h o mep age: w ww.els evier . co m/lo c ate /ys eiz1. Introduction
Epileptic disorders are the clinical result of excitatory and
inhibitory system imbalance within the central nervous system.1
Surgical removal of the epileptic focus is widely accepted as an
effective therapy for selected patients with medically refractory
epilepsy; however, there is no consensus regarding accurate
predictors of surgical outcome due to the use of heterogeneous
study groups, differences in surgical procedures and duration of
follow-up, and varying deﬁnitions of surgical success and failure.
The primary measure of the outcome of epilepsy surgery (ES) is
the end of seizures, and secondary outcome measures are the
frequency and severity of seizures, quality of life, level of disability,
and mortality.2–5 Transcranial magnetic stimulation (TMS) has* Corresponding author. Tel.: +90 506 843 31 22/312 304 44 93;
fax: +90 312 304 59 00.
E-mail address: iipekdal@yahoo.com (H.&. Ipekdal).
1059-1311/$ – see front matter  2011 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2011.07.009been used to non-invasively and almost painlessly investigate the
human cerebral cortex. The motor threshold (MT) and cortical
silent period (CSP), and intracortical inhibition and intracortical
facilitation have been used to evaluate motor cortex excitability.6
Cortical excitability is likely to change after surgical removal of
the epileptic focus;7,8 therefore, TMS parameters may be useful for
predicting the outcome of ES. The present study aimed to assess
the value of the MT and CSP as predictors of the outcome of
temporal lobe epilepsy surgery (TLES).
2. Materials and methods
The study included 10 patients (8 female and 2 male) aged 25–39
years (mean age: 30.7 years) with drug-resistant temporal lobe
epilepsy (Table 1). The patients underwent pre-surgical monitoring
at Gu¨lhane Military Medical Hospital, Department of Neurology,
Epilepsy Monitoring Unit, Ankara, Turkey between January 2005 and
May 2009. Epileptic foci were identiﬁed and surgical techniques
were chosen based on the results of video-electroencephalographyvier Ltd. All rights reserved.
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O¨. Karadas¸ et al. / Seizure 20 (2011) 775–778776(v-EEG) monitoring, brain magnetic resonance imaging (MRI),
single-photon emission computed tomography (SPECT), and posi-
tron emission tomography (PET), and neurophysiological testing. All
of the patients provided written informed consent to undergo TLES,
and TMS testing before and after TLES. The Gu¨lhane Military Medical
Hospital Ethics Committee approved the study protocol.
Patients 1 and 5 underwent anteromedial temporal lobectomy
(AMTL), and the others underwent AMTL and amygdalohippo-
campectomy (AHCT). During AMTL, 3.5 cm of the temporal pole
(from the temporal tip) was removed, including half of the superior
temporal gyrus, and the middle and inferior temporal gyri. During
AHCT, the amygdala, anterior part of the tail of the hippocampus,
and the entire head and body of the hippocampus and
parahippocampal gyrus were surgically removed. Following
surgery, the patients’ antiepileptic drug (AED) regimens remained
unchanged. Additionally, pre-surgical and post-surgical AED blood
levels were identical and within therapeutic ranges. Patient
characteristics are shown in Table 1.
TMS testing was performed 7 days prior to surgery by a
neurologist blinded to the location of each patient’s epileptic focus.
TMS testing was repeated 3 months post surgery by another
neurologist blinded to the pre-surgery measurements. TMS testing
in patients 4 and 7 – whose seizures persisted post TLES – was
performed at least 3 days after they had seizures. TMS was
performed while the patients were in a seated position, using a 9-
cm diameter circular coil (Dantec MC125) capable of generating a
peak magnetic ﬁeld of 1.0 T. Responses of the abductor pollicis
brevis (APB) muscles were recorded bilaterally with a Dantec
Evolution EMG apparatus, using Ag–Cl surface electrodes. The coil
was placed over the scalp projecting the motor cortex area about
7 cm lateral of the vertex. The position of the coil was changed
slightly and the stimulus was administered until the optimal
position for APB muscle response was determined.8–10
2.1. MT measurement
MT was deﬁned as the lowest intensity stimulus required to
elicit an MEP 50  10-mV in amplitude from the resting APB muscle,
with 5 successful trials out of 10. Initial stimulus intensity was 30%
of the maximum stimulus intensity and was increased by 1–5% until
we obtained the MT. MT was measured for both APB muscles
independently.
2.2. CSP measurement
CSP-150 and CSP-max measurements were obtained for each
patient. During the procedure patients were requested to contract
their APB muscles using 50% of their maximum contraction force.
For CSP-150 measurement the stimulus intensity was adjusted to
1.5-fold that of the MT measurement for the same APB muscle and
was administered from the contralateral side of the scalp during
contraction of the ABP muscle. CSP-150 was deﬁned as the mean
value of 5 measurements and CSP-max was deﬁned as the mean
value of 5 CSP measurements obtained with the maximum
stimulus intensity.9–12
Seizure-free was deﬁned as no seizure during the follow-up
period. Pre- and post-surgical MT and CSP measurements were
compared, in terms of the side of epileptic focus and the
contralateral side. Statistical evaluation of the data acquired
before and after surgery was performed using the paired t test.
3. Results
None of the patients experienced complications during TMS
testing. Mean pre-surgical MT (as a percentage of maximum
stimulus intensity) was 52.7  2.6% on the ipsilateral side and
Table 2
Pre- and post-surgical MT values.
Mean MT (%)
Ipsilateral side Contralateral side
Pre-surgical 52.7  2.6 53.3  1.7
Post-surgical 53.4  2.9 51.7  1.6
Table 3
Pre- and post-surgical CSP values.
CSP-150 (ms) CSP-max (ms)
Ipsilateral
side
Contralateral
side
Ipsilateral
side
Contralateral
side
Pre-surgical 145.7  11.3 146.3  10.1 153.7  11.2 157.2  12.1
Post-surgical 142.3  12.2 137.2  12.2 147.6  11.8 142.2  12.2
O¨. Karadas¸ et al. / Seizure 20 (2011) 775–778 77753.3  1.7% on the contralateral side. Post-surgical MT was
53.4  2.9% on the ipsilateral side and 51.7  1.6% on the contralat-
eral side (Table 2). Pre- and post-surgical MT values for the ipsilateral
and contralateral sides did differ signiﬁcantly (P = 0.42 and P = 0.04,
respectively).
Pre-surgical mean CSP-150 was 145.7  11.3 ms on the ipsilat-
eral side and 146.3  10.1 ms on the contralateral side. Post-surgical
mean CSP-150 was 142.3  12.2 ms on the ipsilateral side and
137.2  12.2 ms on the contralateral side. Differences were not noted
between pre- and post-surgical CSP-150 values on the ipsilateral side,
but post-surgical mean CSP-150 on the contralateral side was
signiﬁcantly shorter than the pre-surgical value (P = 0.19 and
P = 0.008, respectively).
Pre-surgical mean CSP-max was 153.7  11.2 ms on the
ipsilateral side and 157.2  12.1 ms on the contralateral side. Post-
surgical mean CSP-max was 147.6  11.8 ms on the ipsilateral side
and 142.2  12.2 ms on the contralateral side. Post-surgical mean
CSP-max on the ipsilateral and contralateral sides was signiﬁcantly
shorter than the pre-surgical values (P = 0.011 and P = 0.007,
respectively). Additionally, mean CSP-max was signiﬁcantly longer
than mean CSP-150 on the contralateral side post-surgically
(P = 0.005). CSP results are summarized in Table 3.
Post surgery, the patients continued to receive the same AED
treatment they received pre-surgery. Mean duration of follow-up
was 28.8 months (range: 11–57 months); 8 patients were seizure-
free post TLES, whereas patients 4 and 7 had no reduction in
seizure frequency or severity (Table 1).
4. Discussion
The present study’s results indicate that the post-TLES CSP – not
MT – was shorter in the 8 patients that were seizure-free post TLES.
Patients 4 and 7 had no improvement in seizure frequency or
seizure severity post surgery and their MT and CSP values before
and after ES were similar.
Epileptic disorders are characterized by heterogeneous patho-
physiological processes that lead to alteration in the balance
between excitatory and inhibitory inﬂuences at the cortical level. It
has been proven that AEDs can alter the MT and CSP in epilepsy
patients by reorganizing cortical excitability. The MT has been
reported to be low, normal, and high in epilepsy patients. Many
studies have suggested that the discrepancy between MT
measurements might be due to the fact that the MT is a dynamic
phenomenon that varies according to seizure type. Although the
results of studies on the effects of AEDs on the MT are inconsistent,
CSP duration has been reported to decrease following AED
treatment,13,14 which may be a result of the close relationshipbetween the CSP and the GABAergic system. GABA-A receptors
mediate short-duration inhibitory postsynaptic potentials (IPSPs),
whereas GABA-B receptors mediate long-duration IPSPs. Some
researchers propose that CSP duration is an indicator of GABA-B
receptor-mediated motor cortical inhibition.14–16
The epileptic focus can affect excitatory and inhibitory
mechanisms on both the ipsilateral and contralateral sides. Several
studies on focal epilepsy support the notion that the epileptic focus
has bilateral effects that may be stronger on the contralateral side.
The mechanisms underlying these changes remain to be elucidat-
ed; a low local inhibitory level caused by the presence of an
excitatory epileptic focus is 1 hypothesis.9,17,18 As with AED
treatment, surgical excision of the epileptic focus can reorganize
cortical excitability.
La¨ppchen et al. were the ﬁrst to study changes in cortical
excitability following successful ES.9 They observed that the MT on
the ipsilateral side was signiﬁcantly higher than that on the
contralateral side following successful ES. In the present study no
differences in MT on both the ipsilateral and contralateral sides
were observed before and after TLES. Such contradictory results
may be related to the surgical procedures employed or the
dynamic nature of the MT. On the other hand, La¨ppchen et al.
reported that the CSP was prolonged on the ipsilateral side before
ES, which indicates that the epileptic focus has a signiﬁcant affect
on the contralateral hemisphere, and that the changes on the
ipsilateral side were comparatively minor. The CSP was signiﬁ-
cantly shorter on the contralateral side after successful ES,
indicating that there was a reduction in intracortical inhibition
on the contralateral side following ES.9
In the present study CSP-150 and CSP-max on the contralateral
side were shorter in the 8 patients that were seizure-free during
post-surgical follow-up; however, although v-EEG monitoring,
brain MRI, SPECT, and PET, and neurophysiological testing
facilitated identiﬁcation of the epileptic foci, TLES failed in 2
patients (patients 4 and 7) that had no improvement in seizure
frequency or severity during follow-up. Surprisingly, although the
epileptic focus in patient 4 was located on the left side before
surgery, v-EEG monitoring performed 14 months post surgery
showed that the epileptic focus was on the left side. Furthermore,
MT, CSP-150, and CSP-max measurements on the ipsilateral and
contralateral sides pre- and post surgery did not differ in patients 4
and 7. Additionally, as both CSP-150 and CSP-max measurements
on the contralateral side were the same, we recommend using CSP-
150 instead of CSP-max in order to avoid the potential side-effects
of TMS testing.
Researches have shown that TLES can result in complete seizure
remission rates of up to 80% in patients with mesial temporal
sclerosis and unilateral seizures. The seizure-free rate after TLES in
patients with extratemporal non-lesional epilepsy is 30–40%.19
The duration of post-surgical follow-up is important in determin-
ing seizure-free and quality of life outcomes following TLES. It has
been suggested that outcome at 1 year post TLES is a good predictor
of long-term outcome.20–24
The main limitations of the present study are the small number
of patients and the lack of ﬁnal diagnoses supported by
histopathology. Additionally, the present results may have been
affected by the different surgical procedures employed; however,
the surgical procedures were chosen based on the tests used to
evaluate the patients and identify the epileptic foci, and the clinical
experience of the neurosurgeons. Larger well-designed studies are
needed in order to obtain more deﬁnitive results. There is a
possibility that TMS testing in the 2 patients that still had seizures
post surgery may have contributed to the persistence of the
seizures; however, we think it unlikely as we performed TMS
testing 5 days after seizure in patient 4 and 9 days after seizure in
patient 7.
O¨. Karadas¸ et al. / Seizure 20 (2011) 775–778778Although the duration of post-surgical follow-up is essential for
the assessment of seizure-free outcome of TLES, the present results
indicate that evaluation of the difference between pre- and post-
TLES CSP may be predictive of clinical outcome. Although the
present study group was small, the ﬁndings in patients 4 and 7
indicate that unaltered CSP values following TLES may be related to
a poor outcome; however, the results of this small-scale feasibility
study indicate that CSP may be a useful predictor of longer-term
post surgical outcome and that larger prospective studies are
warranted.
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